|
|
|
| home | genetic news | bioinformatics | biotechnology | literature | journals | ethics | positions | events | sitemap |
Anthrax Toxin Inhibitor Designed
|
Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have engineered a powerful inhibitor of anthrax toxin that worked well in small-scale animal tests.
Led by NIAID grantees Ravi S. Kane, Ph.D., of Rensselaer Polytechnic Institute, in Troy, NY, and Jeremy Mogridge, Ph.D., of the University of Toronto, the investigators built a fatty bubble studded with small proteins that can cling tightly to the cell membrane receptor-binding protein used by anthrax toxin to gain entry into a host cell. The research appears in the April 23 online edition of the journal Nature Biotechnology .
Message posted by: Rashmi Nemade
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser. Use the links below to share this article on the social bookmarking site of your choice. Read more about social bookmarking at Wikipedia - Social Bookmarking |
Souped-Up T Cells Making an Impact on Reproduction Fighting Neuroblastoma Neuronal Contribution to Risk of Multiple Sclerosis Risk Variants for Intracranial Aneurysm Duplicitous Role for Classic Cancer Molecule Monkey Vaccine Fights Off AIDS Engineered DNA 'Scissors' Show Promise Cancer Genome Sequenced The Promise of Personal Genomics Widespread Alternative Splicing more news ... |
Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S. Zollmann.
7.0 © 1995-2008 HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint.